scispace - formally typeset
Open AccessJournal ArticleDOI

Translational research: Crossing the valley of death

Declan Butler
- 11 Jun 2008 - 
- Vol. 453, Iss: 7197, pp 840-842
Reads0
Chats0
TLDR
A chasm has opened up between biomedical researchers and the patients who need their discoveries and whether the US National Institutes of Health can bridge the gap.
Abstract
A chasm has opened up between biomedical researchers and the patients who need their discoveries. Declan Butler asks how the ground shifted and whether the US National Institutes of Health can bridge the gap.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Delivering affordable cancer care in high-income countries

TL;DR: Urgent solutions range from re-engineering of the macroeconomic basis of cancer costs (eg, value-based approaches to bend the cost curve and allow cost-saving technologies), greater education of policy makers, and an informed and transparent regulatory system.
Journal ArticleDOI

Defining translational research: implications for training.

TL;DR: The authors argue that the approach to designing and evaluating the success of translational training programs must be flexible enough to accommodate the needs of individual institutions and individual trainees within the institutions but that it must also be rigorous enough to document that the program is meeting its short-, intermediate-, and long-term objectives and that its trainees are meeting preestablished competency requirements.
Journal ArticleDOI

When complexity science meets implementation science: a theoretical and empirical analysis of systems change

TL;DR: What implementation science can learn from complexity science is discussed, and some of the properties of healthcare systems that enable or constrain the goals the authors have for better, more effective, more evidence-based care are teased out.
Journal ArticleDOI

Financing Renewable Energy: Who is Financing What and Why it Matters

TL;DR: In this paper, the authors analyze the asset portfolios of different renewable energy technologies financed by different financial actors according to their size, skew and level of risk, and construct a heuristic index of risk that varies with the technology, time, and country of investment.
Journal ArticleDOI

Funding of US biomedical research, 2003-2008

TL;DR: After a decade of doubling, the rate of increase in biomedical research funding slowed from 2003 to 2007, and after adjustment for inflation, the absolute level of funding from the National Institutes of Health and industry appears to have decreased by 2% in 2008.
Related Papers (5)